| Tecentriq (atezolizumab) / Roche |
| Completed | N/A | 353 | Europe | Renal Tolerance to Immunotherapy | Hospices Civils de Lyon | Adverse Effect, Renal Toxicity | 10/17 | 10/17 | | |
RAFALE, NCT03387540: Evaluation of Reporting of Immune Checkpoint Inhibitor Associated Cardio-vascular Adverse Reactions |
|
|
| Completed | N/A | 104 | Europe | ICI | Groupe Hospitalier Pitie-Salpetriere, Institute of Cardiometabolism and Nutrition, France, Vanderbilt University, Vanderbilt University Medical Center | Myocarditis, Cardiac Complication | 12/17 | 12/17 | | |
| Completed | N/A | 1000 | Europe | Immune checkpoint inhibitor | Groupe Hospitalier Pitie-Salpetriere, Institut National de la Santé Et de la Recherche Médicale, France | Arthritis, Cancer, Cardiac Disease, Endocrine System Diseases, Autoimmune Diseases, Ophthalmopathy, Myositis, Neuropathy | 09/18 | 09/18 | | |
NCT04115410: PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study |
|
|
| Unknown status | N/A | 4724 | NA | PD-1 inhibitor, OPDIVO, KEYTRUDA, TECENTRIQ, Chemotherapy Drugs, Cancer, Carboplatin, Cisplatin, Vinorelbine, Gemcitabine, Pemetrexed, Docetaxel, Vinblastine, Mitomycin C, Gefitinib, Erlotinib, Afatinib, Crizotinib, Ceritinib, Alectinib, Osimertinib | Sungkyunkwan University, Ministry of Food and Drug Safety, Korea | Carcinoma, Non-Small-Cell Lung, Immune-Related Adverse Events | 09/21 | 12/21 | | |
| Terminated | N/A | 1 | Europe | 89Zr-atezolizumab PET scans | University Medical Center Groningen | Lobular Metastatic Breast Cancer | 05/22 | 05/22 | | |
| Completed | N/A | 826 | RoW | TACE+ICIs, TACE | Zhongda Hospital | Hepatocellular Carcinoma | 05/22 | 02/23 | | |
| Recruiting | N/A | 221 | Europe | Treatment with immune checkpoint inhibitors., Blood tests. | Hospital Universitario Araba, Hospital de Basurto, Hospital Donostia, Complejo Hospitalario de Navarra, Hospital Galdakao-Usansolo | Cancer, Metastatic Cancer, Solid Organ Cancer | 10/23 | 12/23 | | |
IBFIC, NCT05260606: Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer |
|
|
| Recruiting | N/A | 100 | RoW | F-18 FDG PET/CT | Samsung Medical Center | Carcinoma, Non-Small-Cell Lung, Immune Checkpoint Inhibitors | 12/25 | 12/25 | | |
NCT04680598: Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study |
|
|
| Recruiting | N/A | 800 | RoW | ICI, Antiviral Prophylaxis | Sun Yat-sen University, Kaiping Central Hospital, Guangzhou No.12 People's Hospital, ZhongShan People 's Hospital | Hepatocellular Carcinoma | 12/23 | 12/23 | | |
| Recruiting | N/A | 1800 | Europe | Nivolumab, Opdivo, Pembrolizumab, Keytruda, Ipilimumab, Yervoy, Durvalumab, Imfinzi, Tremelimumab, CP-675,206, Atezolizumab, Tecentriq, Bevacizumab, Avastin | CCTU- Cancer Theme, Microbiotica Ltd | Melanoma, Renal Cancer, Lung Cancer | 07/24 | 07/25 | | |
JOCARDITE, NCT04294771: JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors |
|
|
| Recruiting | N/A | 500000 | Europe | ICI, Immune checkpoint inhibitors | Groupe Hospitalier Pitie-Salpetriere | Myocarditis, Cardiomyopathies, Heart Diseases, Cardiovascular Diseases, Pericarditis, Vasculitis | 01/25 | 01/25 | | |
IMMUNOVASC, NCT05655663: Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer |
|
|
| Recruiting | N/A | 30 | Europe | Vascular investigation | Centre Henri Becquerel | Head and Neck Cancer, Lung Cancer | 02/25 | 12/25 | | |
| Recruiting | N/A | 69 | US | Blood Testing | University of Colorado, Denver, Cancer League of Colorado | Cancer, Metastatic Cancer | 05/25 | 05/27 | | |
NCT04180072: Atezolizumab Plus Bevacizumab With HCC and HBV Infection |
|
|
| Recruiting | N/A | 48 | RoW | Atezolizumab, Tecentriq, Bevacizumab, Avastin | National Health Research Institutes, Taiwan, National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, Mackay Memorial Hospital, Changhua Christian Hospital, China Medical University Hospital, National Cheng-Kung University Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Taichung Veterans General Hospital | Carcinoma, Hepatocellular | 12/25 | 12/25 | | |
